Keyword: University of California San Diego
A study of Proteus Digital Health’s ingestible pill sensor found it performed better than directly monitoring drug adherence.
With $46 million, Boundless is using a new understanding of amplification mutatons to create a new class of drugs to fight difficult-to-treat cancers.
UC San Diego bioengineers prolonged the function of gene circuits that can be used to produce and deliver cancer drugs.
Raj Krishnan discusses building Biological Dynamics, isolation methods for diagnostic testing and more.
Understanding aging in cells beyond the brain could lead to new therapies for diabetes and more, Salk scientists say.
Locana raised $55 million to expand its platform and pipeline for diseases caused by problems in RNA that stop the production of essential proteins.
An enzyme that works on leptin receptors and a receptor protein called MC3R could be anti-obesity drug targets.
The past week ushered in news about a toxin in scorpion venom that may relieve RA and a skin bacterium with anti-cancer powers.
Biotech news over the last week included a reversible sealant to shore up eye injuries and a promising gene therapy for the immune disorder known as "bubble boy" disease.
Broad Institute scientists have created an RNA-editing method that makes reversible changes to DNA possible.